About Claris Bio
Claris Bio is a private company based in Half Moon Bay, California. It has reported $115,837,637 raised in five offerings on Form D since April 2020. Its chief executive is Stephen Brady.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 25, 2025 | Aug 7, 2026amended Aug 12, 2026 | $55,737,646of $121.4M target | 14 | $3.9M | Equity, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 12, 2025 | Sep 22, 2025 | $2,300,000fully sold | 6 | $383K | DebtRule 506(b) | Form D ↗ |
| Feb 26, 2025 | Mar 7, 2025 | $3,299,999of $3.3M target | 6 | $549K | DebtRule 506(b) | Form D ↗ |
| Dec 28, 2023 | Jan 8, 2024 | $9,999,998fully sold | 3 | $3.3M | EquityRule 506(b) | Form D ↗ |
| Apr 13, 2020 | Apr 27, 2020amended Oct 24, 2023 | $44,499,994fully sold | 6 | $7.4M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, five offerings | $115,837,637 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Claris Bio's Form D filed Aug 12, 2026.
MF
Meredith Fisher
Director
RD
Reza Dana
Director
KH
Kenneth Harrison
Director
MH
Matt Hobson
Director
MD
Michael Dybbs
Director
MR
MG
Marc de Garidel
Director